Hoffman, V, Hallas, J, Linder, M, Margulis, A V, Suehs, B T, Arana, A, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, N S, Appenteng, K, de Vogel, S & Seeger, J D 2021, ' Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: Findings from a non-interventional, real-world data safety study ', Pharmacoepidemiology and Drug Safety, vol. 30, no. Suppl. 1, pp. 85 .